Abstract
We describe an unusual case of bilateral breast cancer synchronous with pituitary macroprolactinoma in a young male. Up to date, only very few of such cases have been described worldwide and to our knowledge this is the first one in which both breast cancer and pituitary macroadenoma have been found together at the time of presentation. A 45-year-old male was diagnosed as having a pituitary macroprolactinoma and bilateral breast cancer on the basis of hypogonadism (testosterone 2.9 pmol/l) with very high levels of prolactin (33,100 U/l), typical neuroradiologic finding of a pituitary macroadenoma, marked bilateral gynecomastia with mammographic pattern highly suspected for cancer and subsequent hystological confirmation. Bilateral mastectomy was performed and medical therapy with bromocriptine 10 mg/day was started. After 2-year follow-up the patient is disease-free. Hormonal, neuroradiological and oncological patterns are all negative or markedly improved. We stress the importance of prolactin for its possible biological effects on breast cancer induction or growth. Moreover in any case of hyperprolactinemia we suggest a mammographic examination and, in the case of breast cancer, at least a baseline hormonal profile.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Olsson H., Ramstam J. Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J. Natl. Cancer Inst. 1988, 80: 679–683.
Volm M.D., Talamonti M.S., Thangavelu M., Gradishar W.J. Pituitary adenoma and bilateral male breast cancer: an unusual association. J. Surg. Oncol. 1997, 64: 74–78.
Giaume M., Calcina G.G., Briglia R. Carcinoma bilaterale della mammella maschile. Oncologia, Minerva Medica, 1986, 77: 989–993.
Crichlow R.W., Galt S.W. Male breast cancer. Surg. Clin. North Am. 1990, 70: 1165–1177.
Olsson H., Alm P., Kristoffersson U., Landin-Olsson M. Hypophyseal tumour and gynecomastia preceding bilateral breast cancer development in a man. Cancer 1984, 53: 1974–1977.
Haga S., Watanabe O., Shimizu T., Iida T., Imamura H., Kajiwara T., Fujibayashi M. Breast cancer in a male with prolactinoma. Surg. Today 1993, 23: 251–255.
Crichlow R.W. Carcinoma of the male breast. Surg. Gynecol. Obstet. 1972, 134: 1011–1019.
Calabresi E., De Guili G., Becciolini A., Giannotti P., Lombardo G., Serio M. Plasma estrogens and androgens in male breast cancer. J. Steroid Biochem. 1976, 7: 605–609.
Hayward J. Hormones and human breast cancer. Springer Verlag, Berlin, 1970, p. 113.
Bavafa S., Reyes C.V., Choudhuri A.M. Male breast carcinoma: an updated experience at a veterans administration hospital and review of the literature. J. Surg. Oncol. 1983, 24: 41–45.
Mioduszewski O., Woszarowski T., Gorski C. The influence of hormones on breast cancer in vitro in relation to the clinical course of the disease. In: Forrest A.P.M., Kunkler P.B. (Eds.), Prognostic factors in breast cancer. Livingstone, Edimburgh, 1968. p. 347.
Mertani H.C., Garcia-Caballero T., Lambert A., Gerard F., Palayer C., Boutin J.M., Vonderhaar B.K., Waters M.J., Lobie P.E., Morel G. Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int. J. Cancer 1998, 79: 202–211.
Ortega J.V., Longridge N.S. Fracture of the sellae turcicae. Injury 1974, 6: 335–337.
Crampton M.R. Hypotalamic lesions following closed head injury. Brain 1971, 94: 165–172.
Welsh C.W., Nagasawa H. Prolactin and murine mammary tumorigenesis. Cancer Res. 1977, 37: 951–963.
Reynolds C., Montone K.T., Powell C.M., Tomaszewski J.E., Clevenger C.V. Expression of prolactin and its receptor in human breast carcinoma. Epidemiology 1997, 138: 5555–5560.
Vonderhaar B.K. Prolactin involvement in breast cancer. Endocr. Rel. Cancer 1999, 6: 389–404.
Surmacz E. Function of the IGF-I receptor in breast cancer. J. Mammary Gland Biol. Neoplasia 2000, 5: 95–105.
Strain A.J., Ingleton P.M. Growth hormone- and prolactin-induced release of insulin-like growth factor by isolated rat hepatocytes. Biochem. Soc. Trans. 1990, 18: 1206–1210.
Fruchtman S., Jackson L., Borski R. Insulin-like growth factor-I disparately regulates prolactin and growth hormone synthesis and secretion: studies using the teleost pituitary model. Endocrinology 2000, 141: 2886–2894.
Atkin S.L., Landolt A.M., Foy P., Jeffreys R.V., Hipkin L., White M.C. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro. Clin. Endocrinol. (Oxf.) 1994, 41: 503–509.
Campbell P.G., Skaar T.C., Vega J.R., Baumrucker C.R. Secretion of insulin-like growth factor-I (IGF-I) and IGF-binding proteins from bovine mammary tissue in vitro. J. Endocrinol. 1991, 128: 219–228.
Wennbo H., Gebre-Medhin M., Gritli-Linde A., Ohlsson C., Isaksson O.G., Tornell G. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J. Clin. Invest. 1997, 100: 2744–2751.
Barni S., Lissoni P., Brivio F., Fumagalli L., Merlini D., Cataldo M., Rovelli F., Tancini G. Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin. Tumori 1994, 80: 212–215.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Forloni, F., Giovilli, M., Pecis, C. et al. Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. J Endocrinol Invest 24, 454–459 (2001). https://doi.org/10.1007/BF03351047
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351047